Should Local Rather than National Policy Determine our Approachto Surgery During SARS- CoV-2?

Authors

  • Mar Achalandabaso Boira Division of Hepatobiliary Pancreatic Surgery, Hospital Universitari de Tarragona Joan XXIII, Tarragona, Spain Author
  • Robert Memba Division of Hepatobiliary Pancreatic Surgery, Hospital Universitari de Tarragona Joan XXIII, Tarragona, Spain Author
  • James Richards Addenbrooke´s Hospital, Hills Rd, Cambridge CB2 0QQ, Cambridge, England, UK Author
  • Ricard Sales Division of Hepatobiliary Pancreatic Surgery, Hospital Universitari de Tarragona Joan XXIII, Tarragona, Spain Author
  • Mihai Pavel Division of Hepatobiliary Pancreatic Surgery, Hospital Universitari de Tarragona Joan XXIII, Tarragona, Spain Author
  • Erik Llàcer Division of Hepatobiliary Pancreatic Surgery, Hospital Universitari de Tarragona Joan XXIII, Tarragona, Spain Author
  • Elisabet Julià Division of Hepatobiliary Pancreatic Surgery, Hospital Universitari de Tarragona Joan XXIII, Tarragona, Spain Author
  • Laia Estalella Division of Hepatobiliary Pancreatic Surgery, Hospital Universitari de Tarragona Joan XXIII, Tarragona, Spain Author
  • Rosa Jorba Division of Hepatobiliary Pancreatic Surgery, Hospital Universitari de Tarragona Joan XXIII, Tarragona, Spain Author

DOI:

https://doi.org/10.47363/JGHR/2021(2)122

Keywords:

SARS-CoV-2, Surgery, Respiratory, Complications

Abstract

Purpose: A major disruption of routine hospital services has occurred globally after SARS-CoV-2 pandemic. Current publications are based on large databases collected from hospitals with different characteristics which may not apply to all centres since the impact of SARS-CoV-2 varies depending on the incidence in each area. We studied the incidence of perioperative SARS-CoV-2 infection in surgical patients.


Methods: We performed an observational, retrospective cohort study in patients undergoing surgery between March 16th to May 15th 2020.
Results: Four patients (5.4%) tested positive with SARS-CoV-2, all positive results were obtained postoperatively. SARS-CoV-2 status was known at
the time of surgery in 23 (60%) patients in emergency surgery and 20 patients (57%) in elective surgery. Mortality rate was 13% in emergency surgery with no cases due to SARS-CoV-2 related complications. Nine patients (25.7%) had changes in their management in elective surgery, no deaths were reported and one patient developed SARS-CoV-2 bilateral pneumonia.
Discussion: Our results show that SARS-CoV-2 infection among surgical patients was low in our centre. Changes in policies on surgical activity during the SARS-CoV-2 pandemic should be taken at a regional or hospital level to reflect the local burden of SARS-CoV-2 and availability of resources.

Author Biographies

  • Mar Achalandabaso Boira, Division of Hepatobiliary Pancreatic Surgery, Hospital Universitari de Tarragona Joan XXIII, Tarragona, Spain

    Division of Hepatobiliary Pancreatic Surgery, Hospital Universitari de Tarragona Joan XXIII, Tarragona, Spain

  • Robert Memba, Division of Hepatobiliary Pancreatic Surgery, Hospital Universitari de Tarragona Joan XXIII, Tarragona, Spain

    Division of Hepatobiliary Pancreatic Surgery, Hospital Universitari de Tarragona Joan XXIII, Tarragona, Spain

  • James Richards, Addenbrooke´s Hospital, Hills Rd, Cambridge CB2 0QQ, Cambridge, England, UK

    Addenbrooke´s Hospital, Hills Rd, Cambridge CB2 0QQ, Cambridge, England, UK

  • Ricard Sales, Division of Hepatobiliary Pancreatic Surgery, Hospital Universitari de Tarragona Joan XXIII, Tarragona, Spain

    Division of Hepatobiliary Pancreatic Surgery, Hospital Universitari de Tarragona Joan XXIII, Tarragona, Spain

  • Mihai Pavel, Division of Hepatobiliary Pancreatic Surgery, Hospital Universitari de Tarragona Joan XXIII, Tarragona, Spain

    Division of Hepatobiliary Pancreatic Surgery, Hospital Universitari de Tarragona Joan XXIII, Tarragona, Spain

  • Erik Llàcer, Division of Hepatobiliary Pancreatic Surgery, Hospital Universitari de Tarragona Joan XXIII, Tarragona, Spain

    Division of Hepatobiliary Pancreatic Surgery, Hospital Universitari de Tarragona Joan XXIII, Tarragona, Spain

  • Elisabet Julià, Division of Hepatobiliary Pancreatic Surgery, Hospital Universitari de Tarragona Joan XXIII, Tarragona, Spain


    Division of Hepatobiliary Pancreatic Surgery, Hospital Universitari de Tarragona Joan XXIII, Tarragona, Spain

  • Laia Estalella, Division of Hepatobiliary Pancreatic Surgery, Hospital Universitari de Tarragona Joan XXIII, Tarragona, Spain

    Division of Hepatobiliary Pancreatic Surgery, Hospital Universitari de Tarragona Joan XXIII, Tarragona, Spain

  • Rosa Jorba, Division of Hepatobiliary Pancreatic Surgery, Hospital Universitari de Tarragona Joan XXIII, Tarragona, Spain

    Division of Hepatobiliary Pancreatic Surgery, Hospital Universitari de Tarragona Joan XXIII, Tarragona, Spain

Downloads

Published

2021-09-30